Summary Combination of photosensitizers with carrier molecules has been shown to enhance the efficiency of photodynamic therapy (PDT 
not provide any pronounced preferential or selective tumour affinity (Henderson and Dougherty, 1992) . Better methods of localization in which sensitizers are combined with carriers that recognize the target tissue may therefore be useful in certain instances in order to increase the selective accumulation of the PS within the tumour (Jori, 1990; Hasan, 1992; Hamblin and Newman, 1994) . Such delivery systems include monoclonal antibodies (MAbs) (Mew et al, 1983; Oseroff et al, 1986; Jiang et al, 1991) , liposomes (Jori, 1990; Jori and Reddi, 1990) , low-density lipoproteins (LDLs) (Mosley et al, 1981; Jori et al, 1984; SchmidtErfurth et al, 1994) and microspheres (Bachor et al, 199 la) . MAbs exhibit the highest selectivity, but their uptake by the target tissue is limited by vascular barrier problems and rapid clearance by the reticuloendothelial system. Repetitive use of non-human-derived antibody conjugates invariably elicits an immune response, leading to the formation of anti-antibodies.
Owing to the inherent dual selectivity of PDT through preferential PS localization and spatial control of photoactivation, the requirement for the specificity of carrier systems used in PDT could, in principle, be less stringent than for modalities, such as chemo-and radiotherapy. For this study, we selected covalent conjugates of an endogenous delivery system, human LDL, which is known to possess high-affinity receptors on certain neoplastic and proliferating cells at significantly increased numbers (Gal et al, 1981; Vitols et al, 1985) . A number of investigators have demonstrated that photosensitizers mixed non-covalently with LDL before administration showed enhanced photodynamic activity compared with the administration of the photosensitizer alone (Mosley et al, 1981; Jori, 1984 Jori, , 1990 Jori et al, 1990; Maziere et al, 1990; Schmidt-Erfurth et al, 1994) . However, covalently linked LDL-PS conjugates have rarely been used in PDT. There has been one report of covalent conjugates between LDL and the PS haematoporphyrin (Hamblin and Newman, 1994) . These authors found that LDL-HP showed some apoB/E receptor-mediated uptake in HT29 colorectal tumour cells and in fibroblasts, but a dramatic increase in uptake via the apoB/E receptor-mediated phagocytosis pathway, which is characteristic of macrophage-type cells (Suits et al, 1989) . A comparison with non-covalent mixture of HP-LDL was not made.
The use of covalent conjugates might be advantageous as it obviates the exchange of the PS with non-tumour-targeting blood components. The goal of the experiments described below was to determine whether the covalent coupling of sensitizer to the lipoprotein carrier could enhance cellular uptake and whether increased uptake would translate into enhanced phototoxicity. A critical issue in any such investigation is the synthesis of the covalent conjugate without significant interference with the receptor recognition site. In this study, we report conditions to bind LDL molecules covalently to a second-generation photosensitizer, chlorin e6 (Ce6). Recognition by the LDL-receptor and uptake were tested in proliferating human fibroblasts with characteristically high receptor activity (Anderson et al, 1978) . Subsequently, Ce6-LDL conjugates were used for the targeted photosensitization of human retinoblastoma cells in vitro. Uptake mechanisms were studied with respect to their receptor dependence and whether the compound was actively intemalized into the target cells.
MATERIALS AND METHODS Cells
Human skin fibroblasts (GM 03348 C) were purchased from the Human Genetic Mutant Cell Depository (Camden, NJ, USA). Cells were grown in modified Eagle medium supplemented with 5% inactivated (Gibco, Grand Island, NY, USA) fetal bovine serum (FBS) in a 37°C, 95% air, 5% carbon dioxide atmosphere. For experiments, cells from stock cultures from passage 10-12 in exponential growth phase were harvested, counted and plated into 35-mm-diameter plastic dishes in appropriate numbers. Y79 human retinoblastoma cells (American Type Culture, Rockville, MD, USA) were maintained as a suspension in a humidified atmosphere of 5% carbon dioxide, 95% air at 37°C in Dulbecco's modified Eagle medium supplemented with 10% horse serum and 2.5% FBS. For experimental use, cells were plated on 35-mm tissue-culture dishes previously coated with poly-D-lysine (0.1 mg ml,-' Sigma, St Louis, MO, USA).
Preparation of Ce6-LDL conjugates
Human LDL was prepared from plasma by agarose-column chromatography essentially as described by Rudel et al (1974) . All LDL preparations contained 1 mm EDTA. LDL in solution was quantified by measuring the protein content by a Lowry test (Larson et al, 1986 ). Ce6 (Porphyrin Products, Logan, UT, USA) was dissolved in 0.1 M aqueous sodium hydroxide, diluted in Dulbecco's phosphatebuffered saline (DPBS) and neutralized with 0.1 M hydrochloric acid. For covalent coupling of Ce6 to LDL a 5-JM Ce6 solution was activated with 0.5 mm I-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC) followed immediately by the drop-wise addition of appropriate amounts of LDL solution, according to the desired ratio of Ce6:LDL. Preparation of Ce6-LDL complexes was performed Figure 4 Uptake of free Ce6 and Ce6-conjugate at different temperatures for human fibroblasts. Free Ce6 is taken up at very low rates at both temperatures. Binding of Ce6-conjugate to surface receptors demonstrates an increased, but stable, uptake at 20C, while 370C facilitates internalization and recycling of receptors, as shown by the enhanced uptake Phototoxicity assay Subconfluent cultures of retinoblastoma cells (typically 1.5-2 x 106 cells per dish) were treated with 4 nmol of Ce6 or Ce6 equivalent in the Ce6-LDL conjugate complex, and incubated for 2 h in 1 ml of complete medium. Cultures were then washed three times with medium and fresh medium (without phenol red) was added. An argon ion pumped-dye laser was used for all irradiations. The light from the dye laser coupled into a 1-mm quartz fibre and focused onto the Petri dishes via microscopic objective lens. Irradiation using 660 nm was performed at an irradiance of 50 m W cm-2 and a fluence of 10 J cm-2 at room temperature. Control dishes contained Taylor ( 1989) . Following appropriate treatments, cells were grown in complete medium for 72 h after irradiation. Medium was removed and 1 ml of 1 mg ml-tetrazolium salt MTT (Sigma) in Hanks' balanced salt solution (HBSS) was added. The plates were reincubated for an additional 4 h. The formazan crystals were dissolved in DMSO and the concentration measured colorimetrically. Control dishes were assumed to represent 100% activity for a given cell line and the toxicity/phototoxicity data were evaluated relative to these controls.
RESULTS
The initial experiments determining optimal binding ratios of Ce6:LDL (Figure 2 ), the effect of covalent binding ( Figure 3 ) and the documentation of receptor-mediated pathways ( Figure 4 ) were carried out on the GM03348C cells. This fibroblast cell line was used as a model for LDL receptor-expressing cells, since the receptor expression is well defined in this cell line (Anderson et al, 1978) and not well defined in the retinoblastoma cells. Results from experiments with retinoblastoma cells were similar ( Figures 5  and 6 ). The results of each set of experiments are discussed below.
Determination of the optimal binding ratio Different binding ratios of Ce6 molecules to the LDL carrier were tested for cellular uptake efficiency. The results are presented in Figure 2 for the fibroblast cell line. Ce6:LDL molar ratios ranged from 10:1, 50:1, 100:1 to 1000:1. Ce6concentrations were determined by spectrophotometry, while the LDL quantification was based on protein content. Optimal results were obtained at a Ce6-LDL ratio of 50:1, which was used for further experiments. Higher binding ratios apparently compromised the receptor affinity. At all time points, uptake of Ce6 covalently bound to LDL at a 50:1 ratio was 4-5 times higher than uptake of free Ce6. Figure 6 ; the arrow represents the 4-h point at which free LDL is added. Presumably, the decrease in Ce6 intracellular content following the addition of free LDL was due to competitive saturation of the LDL receptor ( Figure 6 ). The phototoxicity data on retinoblastoma cells treated with free, complexed and conjugated Ce6 and light are presented in Figure 7 . Consistent with the increased uptake, photosensitization was most British Journal of Cancer (1997) . In addition, Jori and Reddi (1990) and others (Mosley et al, 1981; Allison et al, 1994; Schmidt-Erfurth et al, 1994) (Jori, 1989 ).
Ce6 was selected as a sensitizing agent for this study over haematoporphyrin derivative (HPD) , which is the primary sensitizer used clinically (Weishaupt et al, 1976; Bruce, 1987; Sery et al, 1987; Tse et al, 1989) . Ce6 offers a high singlet oxygen quantum yield and reduced skin phototoxicity (Moan et al, 1987 (Goff et al, 1991 (Goff et al, , 1994 Bachor et al, 1991a, b, c) . LDL seemed to be an ideal carrier owing to the presence of significantly increased numbers of receptors on cells with a high mitotic index (Gal et al, 1981; Vitols et al, 1985) . Since there are no data available on the distribution of LDL receptors on retinoblastoma cells, the conjugate was first tested in fibroblast cultures, for which expression and regulation of the LDL receptor had previously been characterized (Brown and Goldstein, 1975) . The same group later demonstrated targeted phototoxicity using pyrene complexed to LDL in the same cell type (Anderson et al, 1978 (Rudling et al, 1990) , and forming complexes or conjugates of drugs with LDL has been proposed as a means of selectively targeting tumours (Vitols, 1991) . Secondly, the scavenger receptor (SR) is present on cells of the monocyte-macrophage lineage. The SR recognizes a wide range of ligands, including LDL, which has had one-sixth (approximately 60) of its epsilon amino groups (Haberland et al, 1984 ) modified either by acetylation or acylation by lipid oxidation products from LDL oxidation (Parthasarathy, 1991) . Thirdly, the apoB/E-mediated phagocytosis mechanism, present on macrophages, recognizes LDL, which has been less severely modified than described above (Tertov et al, 1989) , and is thought to depend upon an increase in aggregation of the LDL particles (Khoo et al, 1988) . Which, if any, of the above mechanisms was responsible for the increased efficacy of PDT with LDL conjugates in the present study is not clear. It may be that different mechanism(s) will be dominant in different cell types. Differences in the kinetics of Ce6-conjugates in fibroblasts compared with retinoblastoma cells were evident at different temperatures in these series (Figures 4 and 5) . Such information may then be used for designing appropriately modified LDL moieties.
Photodynamic targeting using LDL conjugates 59
Any method of conjugation to a receptor-targeting moiety needs to preserve the receptor recognition capabilities of the targeting molecule. Experiments in this investigation demonstrated that this was the case for Ce6-LDL ratios of up to 50:1. In these experiments, uptake of Ce6-LDL conjugates by fibroblasts and retinoblastoma cells was about five times higher compared with free Ce6 Higher binding ratios than 50:1 gave lower uptake of Ce6, presumably because they compromised the affinity of the receptor recognition site, apoprotein B and E, where Ce6 binding occurred on the LDL protein.
In the present study, increased uptake directly translated into enhanced phototoxicity in the same range as the uptake. Since chemical binding is known to cause changes in the molecular photophysics and, hence, in factors such as the singlet oxygen quantum yield of a sensitizer as well as its intracellular distribution (Bachor et al, 1991c) , the proportional increase or decrease in cell kill is rarely predictable. Exposure to higher doses than 10 J cm-2 might have increased the photocytotoxicity further; however, the borderline radiant exposure used appropriately demonstrated the differential effects of free, complexed and bound Ce6. Although, as shown in Figure 3 , the photosensitizer content of cells is similar for free and complexed Ce6, the complex appeared to be slightly more phototoxic than the free Ce6. This may be due to Ce6-induced photosensitization of LDL, resulting in lipid peroxidation products, which may be toxic to cells (Brown and Goldstein, 1975; Maziere et al, 1990) . Alternatively, the small difference in the uptake or the intracellular site of Ce6 localization is responsible for the increased phototoxicity with the Ce6-LDL complex.
The initial experiments with PDT and retinoblastoma cells were performed by Sery et al (1979) . Two cell lines, Y79 and WERI-RB 1, were photosensitized with HPD and white light, and the resulting photodynamic effects were documented. Cell suspensions were supplemented with HPD, incubated for different time intervals and subsequently irradiated in the presence of HPD. The highest phototoxicity was achieved when sensitization periods of cell-dye contact were 6 h or longer. This extended interval demonstrates the slow rate of non-specific accumulation of free photosensitizer. When the HPD was washed out of the incubation medium before irradiation, phototoxicity was significantly reduced, similar to our observations with free Ce6. Apparently, free HPD was not firmly bound to cells or internalized, but loosely attached through non-specific interactions or diffusion, in a rapidly reversible processes. When sensitizer bound to LDL was used in our study, intensive washing did not reduce the phototoxicity of Ce6-LDL, while free Ce6 was easily removed from the cells owing to lack of receptor binding, consistent with Sery's experience.
Furthermore, HPD at very high concentrations of 16.7 gM was required to achieve phototoxicity. Addition of serum to the incubation medium induced an inhibitory effect on HPD phototoxicity, which supports the important role of plasma factors for the delivery (and removal) of free sensitizers.
Winther (1989) studied the effect of PF on a retinoblastoma-like cell line, EXP-5, in vitro, after in vivo experiments with the same cell line exhibited a tumour response of only 33%. Their results indicated an extremely high sensitivity of retinoblastoma cells in vitro to photodynamic treatment. A directly proportional relation between light and PS dose and the level of phototoxicity was found. In our study, an increased intracellular sensitizer concentration led to an enhanced phototoxicity, with an increased PS uptake with the use of LDL carriers. Direct tumour cell targeting, therefore, may represent a realistic approach to increasing the efficient PS concentration in tumour tissue, since the administration of higher PS doses or an extension of the incubation interval has limitations in vivo.
The contrast in high in vitro toxicity and low in vivo effects observed by Winther (1989) is often explained by the influence of PDT-induced hypoxia (Henderson and Fingar, 1987 (Zhou et al, 1988) . When the LDL-PS complexes or conjugates are used to deliver the PS for in vivo PDT of tumours, the reaction of these species with endothelial cells must be considered, since this is the barrier through which the PS must pass if tumour cells are to be photosensitized. Endothelial cells express the classical apoB/E receptor (high affinity, low capacity) that leads to endocytosis via coated pits and vesicles to endosomes and then to lysosomes where the apoB is degraded and the cholesterol used in the cell. In addition, approximately 60% of the LDL taken up by the endothelium is transcytosed by non-coated plasmalemmal vesicles or caveolae (low affinity, high capacity) (Simionescu and Simionescu, 1991) . Transcytosis is not saturable (Rutledge et al, 1990) ; in conditions of hyperbetalipoproteinaemia, large amounts of LDL can cross the endothelium (Vasile et al, 1983) . Receptors for mildly oxidized LDL, specifically CD36 (Endenmann et al, 1993) have been found associated with caveolin in endothelium (Lisanti et al, 1994) , but the binding mechanism for native LDL leading to transcytosis are presently unclear.
Endothelial cells do not express the type I and II scavenger receptors (Itakura et al, 1993) found on macrophages, which recognize acetyl-LDL and highly oxidized LDL (Naito et al, 1992) , but nevertheless their interaction with acetyl-LDL is well known (Voyta, 1984 (Hamblin and Newman, 1994) that complex formation between PS and LDL in vivo modifies the behaviour of the LDL (perhaps with some oxidative event), so that the PS-LDL complex behaves similarly to mildly oxidized LDL, being transcytosed by the tumour microvasculature endothelium and accumulated in tumour-associated macrophages. Allison et al (1994) found that the photosensitizer BPD-MA was better delivered to tumours in vivo associated with native LDL than with acetylated LDL. When LDL-bound sensitizers are used, enhanced vascular effects are seen at early exposure, and direct tumour cell kill is mostly found after prolonged intervals, probably following the metabolic pathway of LDL (Zhou et al, 1988 ).
When we used LDL to deliver the PS, benzoporphyrin derivative mono-acid (BPD-MA), to treat an experimental melanoma in vivo, vascular occlusion subsequent to endothelial damage was a prominent feature following treatment soon after BPD-MA injection (Schmidt-Erfurth et al, 1994 , 1995a . In addition, data (Schmidt-Erfurth et al, 1994) were also consistent with direct tumour cell cytotoxicity.
Binding of LDL-sensitizer conjugates to neovascular endothelium in addition to tumour cells has been attributed to receptormediated binding of LDL by endothelial cells (Vlodavsky et al, 1978) . This binding to endothelial cells may provide additional targeting of tumour neovasculature, which would further enhance phototoxicity (Roberts and Hasan, 1992) . The ability of LDL to pass microvascular barriers, particularly when the permeability is increased, as seen in intraocular and other tumours (Roberts and Hasan, 1993) , provides a facilitated access of LDL-conjugates to neoplastic tissue.
In summary, this initial study demonstrates an advantage to using PS-LDL covalent conjugates. No attempt was made in these investigations to optimize the PDT parameters, nor was there any attempt to develop new techniques of conjugate synthesis or of exquisite purification or characterization of the conjugates. These initial encouraging results in the two cell lines tested warrant more rigorous studies and also suggest considering PDT with PS-LDL conjugates for intraocular and other malignancies. The use of carriers could potentially provide a direct and more specific targeting with increased efficiency and selectivity. Furthermore, it widens the repertoire of potential sensitizers based on their phototoxic potential, without the need of inherent selectivity or the ability to form complexes with LDL on the part of the photosensitizer.
